中国循证儿科杂志 ›› 2023, Vol. 18 ›› Issue (5): 349-354.DOI: 10.3969/j.issn.1673-5501.2023.05.004

• 论著 • 上一篇    下一篇

儿童炎症性肠病合并急性胰腺炎11例病例系列报告

仇晓霞,孙桦,王玉环,唐子斐,吴婕,黄瑛   

  1. 复旦大学附属儿科医院消化科上海,201102
  • 收稿日期:2023-08-14 修回日期:2023-11-16 出版日期:2023-10-25 发布日期:2023-10-25
  • 通讯作者: 孙桦

11 children with inflammatory bowel disease complicated with acute pancreatitis: A case series report

QIU Xiaoxia, SUN Hua, WANG Yuhuan, TANG Zifei, WU Jie, HUANG Ying   

  1. Department of Gastroenterology, Children's Hospital of Fudan University, Shanghai 201102, China
  • Received:2023-08-14 Revised:2023-11-16 Online:2023-10-25 Published:2023-10-25
  • Contact: SUN Hua, email: sunhua_05@126.com

摘要: 背景:国内尚缺乏儿童炎症性肠病(IBD)合并急性胰腺炎(AP)的临床病例报道。 目的:总结单中心收治的儿童IBD合并AP病例的临床特征、治疗和转归。 设计:病例系列报告。 方法:回顾性纳入2017年1月至2022年6月在复旦大学附属儿科医院消化科住院的IBD合并AP的连续病例。截取患儿的临床表现,实验室检查、影像学检查和消化内镜检查结果,治疗和转归情况。 主要结局指标:AP相关实验室指标和IBD内镜评分。 结果:研究期间收治的406例IBD患儿中11例(2.7%)合并AP,男9例、女2例,IBD和AP的中位确诊年龄分别为9.8(5.5,13.1)和10.2(5.7,14.0)岁;AP病程中位时间为22(7,56)d。8例在诊断IBD后出现AP,其中5例克罗恩病(CD)、3例溃疡性结肠炎(UC);3例先诊断AP,后诊断CD。确诊IBD和AP时血淀粉酶为238(158,573)U·L-1,血脂肪酶为466(360,1 376)U·L-1,3、6、12个月后均下降,较确诊时差异有统计学意义。9/10例患儿影像学检查提示胰腺病变。8例CD患儿在确诊CD合并AP时的儿童克罗恩病活动指数(PCDAI)和克罗恩病简化内镜评分(SES-CD)分别为36.3(25.6,49.4)分和17.5(7.8,22.2)分,3个月后均降低,差异有统计学意义。3例UC患儿在AP发病时的儿童溃疡性结肠炎疾病活动指数(PUCAI)评分和Mayo内镜评分(MES)分别为40(25,42.5)分和2(2,2.5)分,出院3个月后分别为15(0,30)分和2.5(2,3)分。随访3年,11例患儿均无AP复发;1例UC患儿AP发病前采用5-氨基水杨酸和英夫利昔单抗治疗,AP发病后家长自行停用上述两种药物,随访2年时有持续性高淀粉酶血症、高脂肪酶血症,并出现胰管扩张,随访3年时进展为慢性胰腺炎。 结论:儿童IBD活动期可合并AP,AP可能是IBD的一种少见的肠外表现。在IBD的诊治过程中要注意胰腺功能的评估及随访。

关键词: 炎症性肠病, 克罗恩病, 溃疡性结肠炎, 急性胰腺炎, 儿童

Abstract: Background:Clinical cases of children with inflammatory bowel disease complicated with acute pancreatitis are rarely reported in China. Objective:To summarize and analyze the clinical characteristics, treatment and prognosis of children with inflammatory bowel disease(IBD) with acute pancreatitis(AP) in a single center. Design:Case series report. Methods:The basic characteristics, clinical manifestations, physical examination, laboratory examination, imaging examination, treatment and follow-up information were retrospectively collected and analyzed from continuous cases of inflammatory bowel disease with acute pancreatitis hospitalized in the Department of Gastroenterology at Children's Hospital of Fudan University from January 2017 to June 2022. Main outcome measuresAP-related laboratory indicators and IBD endoscopic score. Results:A total of 406 children with inflammatory bowel disease from January 2017 to June 2022 were retrospectively analyzed, and 11 cases (2.7%) were complicated with acute pancreatitis. Among them, 9 were male and 2 were female. The median age of initial diagnosis of IBD and AP was 9.8(5.5, 13.1) and 10.2(5.7, 14.0) years old, respectively. The median duration of AP disease was 22(7, 56) days. Among the 11 children, IBD was confirmed before AP in 8 cases including 5 cases of Crohn's disease (CD) and 3 cases of ulcerative colitis (UC), and AP was confirmed before CD in 3 cases. Serum amylase was 238 (158,573) U·L-1 and blood lipase was 466 (360,1 376) U·L-1 at the diagnosis of IBD and AP, and both decreased after 3, 6 and 12 months with statistical significance. Imaging examination showed pancreatic lesions in 9/10 cases. The pediatric Crohn's disease activity index (PCDAI) and simplified endoscopic score for Crohn's disease (SES-CD) of 8 CD children were 36.3 (25.6, 49.4) and 17.5 (7.8, 22.2) at the diagnosis of CD and AP, and both decreased after 3 months with statistical significance. The pediatric ulcerative colitis disease activity index (PUCAI) score and Mayo endoscopic score (MES) of the 3 UC children were 40(25, 42.5) and 2(2, 2.5) at the onset of AP, and turned to 15(0, 30) and 2.5(2, 3) after 3 months of discharge. During 3 years of follow-up, there was no recurrence of AP in the 11 children. One UC child treated with 5 aminosalicylic acid and infliximab before onset of AP, who stopped taking the medication themselves after the onset of AP, had persistent hyperamylasemia, hyperlipemia, and pancreatic duct dilatation at 2 years of follow-up, and was progressed to chronic pancreatitis(CP) at 3 years of follow-up. Conclusions:Children with inflammatory bowel disease can be complicated with acute pancreatitis during the active stage, and acute pancreatitis may also be a rare extraintestinal manifestation of inflammatory bowel disease. During the diagnosis and treatment of inflammatory bowel disease, we should pay attention to the evaluation and follow-up of pancreatic function.

Key words: Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Acute pancreatitis, Children